Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-11

Clinical Trial Update: Preoperative IMRT With Concurrent Anlotinib for Localised Extremity or Trunk Sarcoma (SPARE-01) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating preoperative intensity-modulated radiotherapy with concurrent Anlotinib for localized soft tissue sarcoma of the extremities o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anlotinib (anlotinib)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Sarcoma,Soft Tissue, Extremity | Phase 2 | Status: RECRUITING